Patients with haematological malignancies, haemopoietic stem cell transplant recipients and
patients requiring admission to intensive care settings are at high risk for invasive …

Candidemia and invasive candidiasis (C/IC) are life‐threatening opportunistic infections that
add excess morbidity, mortality and cost to the management of patients with a range of …

Invasive candidiasis (IC) includes candidemia, disseminated candidiasis with deep organ
involvement, endocarditis and meningitis. IC has an attributable mortality of 40% to 50% and …

Objective The global burden of invasive fungal disease is increasing. Candida albicans
remains the leading cause of fungal bloodstream infections, although non-albicans candidal …

Invasive candidiasis (IC) is a serious infection caused by several Candida species, and the
most common fungal disease in hospitals in high-income countries. Despite overall …

Invasive candidiasis is an important fungal disease caused by Candida albicans and,
increasingly, non-albicans Candida pathogens. Invasive Candida infections originate most …

Invasive candidiasis (IC) is an important infection in the intensive care unit (ICU) setting
given its association with poor clinical outcomes. The epidemiology of IC is complex and …

Invasive candidiasis occurs frequently in hospitalized patients, and is associated with high
mortality rates due to delays in recognition and initiation of appropriate antifungals …

Invasive candidiasis (IC) has emerged in the last decades as an important cause of
morbidity, mortality, and economic load in the intensive care unit (ICU). The epidemiology of …

Objectives Candidemia is among the most frequent nosocomial bloodstream infections.
Landmark case‐control studies on amphotericin B and fluconazole estimated attributable …